• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管二尖瓣修复术(使用MitraClip)后延长住院时间的预测因素。

Predictors for prolonged hospital stay after transcatheter mitral valve repair with the MitraClip.

作者信息

Ledwoch Jakob, Bertog Stefan, Wunderlich Nina, Doss Mirko, Fichtlscherer Stephan, Teufel Tobias, Herholz Tina, Vaskelyte Laura, Hofmann Ilona, Sievert Horst

机构信息

CardioVascular Center Frankfurt, Sankt Katharinen and University Hospital, Frankfurt, Germany.

出版信息

Catheter Cardiovasc Interv. 2014 Oct 1;84(4):599-605. doi: 10.1002/ccd.25460. Epub 2014 Jun 17.

DOI:10.1002/ccd.25460
PMID:24616248
Abstract

OBJECTIVE

The aim is to find predictors for a prolonged LOHS after MitraClip implantation.

BACKGROUND

Due to its less invasive nature, average length of hospital stay (LOHS) after the MitraClip procedure is shorter compared to mitral valve surgery. However, some patients have a prolonged LOHS.

METHODS

Records of consecutive patients who underwent MitraClip procedure were reviewed. A total of 41 consecutive patients with MitraClip implantation (76 ± 9 years, 59% men) were included. Median hospital stay was 7 days. Hospitalization lasting longer than 7 days was considered prolonged.

RESULTS

Procedural success was achieved in 88% of the cases. In-hospital death occurred in 4 of 41 patients (10%). Patients with a prolonged hospital stay (46%) had a higher EuroSCORE I (22.7% [IQR 10.3-28.3] vs. 6.7% [IQR 3.5-18.3], P = 0.017), a higher STS mortality score (6.1%[(IQR 3.7-7.5] vs. 2.6% [IQR 1.4-4.8]; P = 0.043) and a higher STS long-length-of-stay score (18.9% [IQR 11.3-22.5] vs. 9.6% [IQR 6.2-16.1]; P = 0.039) as well as a lower estimated glomerular filtration rate (eGFR) (41 ml/min/1.73 m(2) [IQR 19-52] vs. 56 ml/min/1.73 m(2) [IQR 49-62]; P = 0.008) than those whose did not. In the multivariate model, lower eGFR was identified as predictor for a prolonged hospitalization.

CONCLUSION

Lower pre-procedure eGFR is independently associated with a longer hospitalization.

摘要

目的

旨在寻找经皮二尖瓣缘对缘修复术(MitraClip)植入术后住院时间延长的预测因素。

背景

由于其侵入性较小,与二尖瓣手术相比,MitraClip术后的平均住院时间(LOHS)较短。然而,一些患者的住院时间会延长。

方法

回顾了连续接受MitraClip手术患者的记录。共纳入41例连续接受MitraClip植入术的患者(76±9岁,59%为男性)。中位住院时间为7天。住院时间超过7天被视为延长。

结果

88%的病例手术成功。41例患者中有4例(10%)在住院期间死亡。住院时间延长的患者(46%)的欧洲心脏手术风险评估系统(EuroSCORE)I评分较高(22.7%[四分位间距10.3 - 28.3] vs. 6.7%[四分位间距3.5 - 18.3],P = 0.017),胸外科医师协会(STS)死亡率评分较高(6.1%[四分位间距3.7 - 7.5] vs. 2.6%[四分位间距1.4 - 4.8];P = 0.043),STS长住院时间评分较高(18.9%[四分位间距11.3 - 22.5] vs. 9.6%[四分位间距6.2 - 16.1];P = 0.039),且估算肾小球滤过率(eGFR)较低(41 ml/min/1.73 m²[四分位间距19 - 52] vs. 56 ml/min/1.73 m²[四分位间距49 - 62];P = 0.008)。在多变量模型中,较低的eGFR被确定为住院时间延长的预测因素。

结论

术前较低的eGFR与较长的住院时间独立相关。

相似文献

1
Predictors for prolonged hospital stay after transcatheter mitral valve repair with the MitraClip.经导管二尖瓣修复术(使用MitraClip)后延长住院时间的预测因素。
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):599-605. doi: 10.1002/ccd.25460. Epub 2014 Jun 17.
2
Percutaneous mitral valve repair with the MitraClip system according to the predicted risk by the logistic EuroSCORE: preliminary results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry.根据逻辑欧洲心脏手术风险评估系统(EuroSCORE)预测的风险,使用MitraClip系统进行经皮二尖瓣修复:来自德国经导管二尖瓣介入治疗(TRAMI)注册研究的初步结果。
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):591-8. doi: 10.1002/ccd.25493. Epub 2014 Apr 30.
3
Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip.经皮缘对缘二尖瓣修复术(MitraClip)治疗后,即刻手术失败预测不良结局。
EuroIntervention. 2014;9(12):1407-17. doi: 10.4244/EIJV9I12A238.
4
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience.经导管二尖瓣夹合术联合二尖瓣修复术治疗因中重度左心室衰竭导致的功能性二尖瓣反流:单中心经验。
Eur J Cardiothorac Surg. 2012 Dec;42(6):920-6. doi: 10.1093/ejcts/ezs294. Epub 2012 Sep 7.
5
Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.接受经皮二尖瓣修复术的高手术风险患者的长期生存率及术前死亡预测因素
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):467-75. doi: 10.1002/ccd.26137. Epub 2015 Aug 13.
6
Percutaneous mitral repair with the MitraClip system in patients with mild-to-moderate and severe heart failure: a single-centre experience.经皮二尖瓣修复术联合 MitraClip 系统治疗轻中度和重度心力衰竭患者:单中心经验。
Cardiovasc Ther. 2014 Apr;32(2):66-73. doi: 10.1111/1755-5922.12058.
7
The influence of a percutaneous mitral repair program on surgical mitral valve volume.经皮二尖瓣修复程序对手术二尖瓣容积的影响。
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1093-7. doi: 10.1016/j.jtcvs.2015.08.025. Epub 2015 Aug 13.
8
In-hospital outcomes of transcatheter mitral valve repair with Mitraclip in patients with pulmonary hypertension: Insights from the National Inpatient Sample.在全国住院患者样本中观察到肺动脉高压患者经导管二尖瓣修复术(Mitraclip)的住院治疗结果。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):E30-E36. doi: 10.1002/ccd.27997. Epub 2018 Dec 2.
9
Impact of sex on short term in-hospital outcomes with transcatheter edge-to-edge mitral valve repair.性别对经导管二尖瓣缘对缘修复术短期院内结局的影响。
Cardiovasc Revasc Med. 2018 Mar;19(2):182-185. doi: 10.1016/j.carrev.2017.07.002. Epub 2017 Jul 10.
10
6-Minute walk test predicts prolonged hospitalization in patients undergoing transcatheter mitral valve repair by MitraClip.6 分钟步行试验可预测行经导管二尖瓣修复术(MitraClip)的患者延长住院时间。
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):566-573. doi: 10.1002/ccd.27600. Epub 2018 Apr 15.

引用本文的文献

1
Impact of post-procedural length of stay on short-term outcomes and readmissions after TAVR and MitraClip.经导管主动脉瓣置换术(TAVR)和二尖瓣夹合术(MitraClip)后住院时间对短期结局和再入院的影响。
Am Heart J Plus. 2022 Apr 1;13:100130. doi: 10.1016/j.ahjo.2022.100130. eCollection 2022 Jan.
2
Anaesthesia for transcatheter mitral valve repair.经导管二尖瓣修复术的麻醉
BJA Educ. 2023 May;23(5):189-195. doi: 10.1016/j.bjae.2023.01.004. Epub 2023 Feb 24.
3
Interrelationship Between Kidney Function and Percutaneous Mitral Valve Interventions: A Comprehensive Review.
肾功能与经皮二尖瓣介入治疗之间的相互关系:一项综合综述。
Curr Cardiol Rev. 2019;15(2):76-82. doi: 10.2174/1573403X14666181024155247.
4
Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.先前经皮缘对缘二尖瓣修复术(PMVR)治疗的患者行 TAVR 会影响 MR 的改善。
PLoS One. 2018 Oct 19;13(10):e0205930. doi: 10.1371/journal.pone.0205930. eCollection 2018.
5
Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).评估胱抑素C和中性粒细胞明胶酶相关脂质运载蛋白作为经皮二尖瓣修复术(MitraClip)患者死亡率预测指标的价值。
Clin Cardiol. 2018 Nov;41(11):1474-1479. doi: 10.1002/clc.23089. Epub 2018 Nov 16.
6
Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).作为经皮二尖瓣修复术(MitraClip)高危患者死亡率预测指标的心肌炎症和重塑过程的特异性生物标志物。
Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.